Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities.
Van Slambrouck C, Huh J, Suh C, Song JY, Menon MP, Sohani AR, Duffield AS, Goldberg RC, Dama P, Kiyotani K, Godfrey J, Fitzpatrick C, Kline J, Smith SM, Jaffe ES, Hartmann S, Venkataraman G. Van Slambrouck C, et al. Among authors: godfrey j. Mod Pathol. 2020 May;33(5):834-845. doi: 10.1038/s41379-019-0428-0. Epub 2019 Dec 10. Mod Pathol. 2020. PMID: 31822802 Free PMC article.
Mechanisms of Immune Tolerance in Leukemia and Lymphoma.
Curran EK, Godfrey J, Kline J. Curran EK, et al. Among authors: godfrey j. Trends Immunol. 2017 Jul;38(7):513-525. doi: 10.1016/j.it.2017.04.004. Epub 2017 May 13. Trends Immunol. 2017. PMID: 28511816 Free PMC article. Review.
An update in treating transformed lymphoma.
Godfrey J, Leukam MJ, Smith SM. Godfrey J, et al. Best Pract Res Clin Haematol. 2018 Sep;31(3):251-261. doi: 10.1016/j.beha.2018.07.008. Epub 2018 Jul 25. Best Pract Res Clin Haematol. 2018. PMID: 30213394 Review.
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
Merryman RW, Carreau NA, Advani RH, Spinner MA, Herrera AF, Chen R, Tomassetti S, Ramchandren R, Hamid M, Assouline S, Santiago R, Wagner-Johnston N, Paul S, Svoboda J, Bair SM, Barta SK, Liu Y, Nathan S, Karmali R, Burkart M, Torka P, David KA, Wei C, Lansigan F, Emery L, Persky D, Smith SM, Godfrey J, Chavez J, Cohen JB, Troxel AB, Diefenbach C, Armand P. Merryman RW, et al. Among authors: godfrey j. Oncologist. 2020 Jun;25(6):e993-e997. doi: 10.1634/theoncologist.2020-0040. Epub 2020 Apr 28. Oncologist. 2020. PMID: 32275786 Free PMC article.
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.
Carreau NA, Pail O, Armand P, Merryman R, Advani RH, Spinner MA, Herrera A, Chen R, Tomassetti S, Ramchandren R, Hamid MS, Assouline S, Santiago R, Wagner-Johnston N, Paul S, Svoboda J, Bair S, Barta S, Liu Y, Nathan S, Karmali R, Burkart M, Torka P, David K, Wei C, Lansigan F, Emery L, Persky D, Smith S, Godfrey J, Chavez J, Xia Y, Troxel AB, Diefenbach C. Carreau NA, et al. Among authors: godfrey j. Oncologist. 2020 Oct;25(10):878-885. doi: 10.1634/theoncologist.2020-0167. Epub 2020 Aug 28. Oncologist. 2020. PMID: 32720734 Free PMC article.
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Trujillo JA, Godfrey J, Hu Y, Huang J, Smith SM, Frigault MJ, DeFilipp Z, Appelbaum D, Pu Y, Feinberg N, Althaus T, Bishop MR, Riedell PA, Kline J. Trujillo JA, et al. Among authors: godfrey j. Blood. 2021 Jun 17;137(24):3454-3459. doi: 10.1182/blood.2020009148. Blood. 2021. PMID: 33881502 Free PMC article. No abstract available.
410 results